Marksans Pharma has informed that it has received one request from a shareholder for issue of duplicate share certificate in lieu of the lost/misplaced original Share Certificate. Its Registrar and Transfer Agent, Bigshare Services has received the completed documents for issuing duplicate share certificate on 5th June, 2023 and pursuant to Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duplicate share certificate is being issued as details enclosed.
The above information is a part of company’s filings submitted to BSE.
